JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dams, E. T. M.
Right arrow Articles by Boerman, O. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dams, E. T. M.
Right arrow Articles by Boerman, O. C.

Vol. 292, Issue 3, 1071-1079, March 2000

Accelerated Blood Clearance and Altered Biodistribution of Repeated Injections of Sterically Stabilized Liposomes1

Els T. M. Dams , Peter Laverman, Wim J. G. Oyen, Gert Storm, Gerrit L. Scherphof, Jos W. M. van der Meer, Frans H. M. Corstens and Otto C. Boerman

Departments of Nuclear Medicine (E.T.M.D., P.L., W.J.G.O., F.H.M.C., O.C.B.) and Internal Medicine (E.T.M.D., J.W.M.M.), University Medical Centre St. Radboud, Nijmegen; Department of Pharmaceutics (G.S.), Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht; and Department of Physiological Chemistry (G.L.S.), University of Groningen, Groningen, the Netherlands

Sterically stabilized liposomes are considered promising carriers of therapeutic agents because they can facilitate controlled release of the drugs, thereby reducing drug-related toxicity and/or targeted delivery of drugs. Herein, we studied the pharmacokinetics and biodistribution of repeated injections of radiolabeled polyethyleneglycol (PEG) liposomes. Weekly injections of 99mTc-PEG liposomes dramatically influenced the circulatory half-life in rats. Biodistribution 4 h after the second dose showed a significantly reduced blood content (from 52.6 ± 3.7 to 0.6 ± 0.1% injected dose (ID), P < .01) accompanied by a highly increased uptake in the liver (from 8.1 ± 0.8 to 46.2 ± 9.8%ID, P < .01) and in the spleen (from 2.2 ± 0.2 to 5.3 ± 0.7%ID, P < .01). At subsequent injections the effect was less pronounced: after the fourth dose, the pharmacokinetics of the radiolabel had almost returned to normal. The same phenomenon was observed in a rhesus monkey, but not in mice. The enhanced blood clearance of the PEG liposomes also was observed in rats after transfusion of serum from rats that had received PEG liposomes 1 week earlier, indicating that the enhanced blood clearance was caused by a soluble serum factor. This serum factor was a heat-labile molecule that coeluted on a size exclusion column with a 150-kDa protein. In summary, i.v. administration of sterically stabilized PEG liposomes significantly altered the pharmacokinetic behavior of subsequently injected PEG liposomes in a time- and frequency-dependent manner. The observed phenomenon may have important implications for the repeated administration of sterically stabilized liposomes for targeted drug delivery.


1 This study was supported by Grant no. NGN 55.3665 from the Technology Foundation (Technologiestichting STW), the Netherlands.


0022-3565/00/2923-1071$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
R. D. Arnold, D. E. Mager, J. E. Slack, and R. M. Straubinger
Effect of Repetitive Administration of Doxorubicin-Containing Liposomes on Plasma Pharmacokinetics and Drug Biodistribution in a Rat Brain Tumor Model
Clin. Cancer Res., December 15, 2005; 11(24): 8856 - 8865.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. C. Semple, T. O. Harasym, K. A. Clow, S. M. Ansell, S. K. Klimuk, and M. J. Hope
Immunogenicity and Rapid Blood Clearance of Liposomes Containing Polyethylene Glycol-Lipid Conjugates and Nucleic Acid
J. Pharmacol. Exp. Ther., March 1, 2005; 312(3): 1020 - 1026.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
H. Sakai, Y. Masada, H. Horinouchi, E. Ikeda, K. Sou, S. Takeoka, M. Suematsu, M. Takaori, K. Kobayashi, and E. Tsuchida
Physiological Capacity of the Reticuloendothelial System for the Degradation of Hemoglobin Vesicles (Artificial Oxygen Carriers) after Massive Intravenous Doses by Daily Repeated Infusions for 14 Days
J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 874 - 884.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
W. M. Li, L. D. Mayer, and M. B. Bally
Prevention of Antibody-Mediated Elimination of Ligand-Targeted Liposomes by Using Poly(Ethylene glycol)-Modified Lipids
J. Pharmacol. Exp. Ther., March 1, 2002; 300(3): 976 - 983.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. Laverman, M. G. Carstens, O. C. Boerman, E. Th. M. Dams, W. J. G. Oyen, N. van Rooijen, F. H. M. Corstens, and G. Storm
Factors Affecting the Accelerated Blood Clearance of Polyethylene Glycol-Liposomes upon Repeated Injection
J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 607 - 612.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
S. M. Moghimi, A. C. Hunter, and J. C. Murray
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Pharmacol. Rev., June 1, 2001; 53(2): 283 - 318.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.